CSPC Weisheng Pharmaceutical (Shijiazhua
Exhibitor at Fi Europe 2025 stand 72P41 & stand 72P41, Pet Food
About us
As the Chinese innovative leading pharmaceutical enterprise ,CSPC is engaged in Innovative drug research and development, production and sale. CSPC has a total asset of RMB 41 billion and around 25,000 employees up to now. Listed in Hong Kong（01093.HK）with market value of more than HK$ 100 billion and being one of the Hang Seng Index constituent stocks, CSPC has been the first pharmaceutical share since the past 50 years.
All for good medicine, All for mankind’s health. CSPC continuously develops its innovative products and continuously enhances production capacity. For now, it has 1252 production document number and a wide product portfolio. All of these can meet the health needs of people with different diseases.
Specs about this supplier
| Sales markets | Africa; Asia; Central/South America; Eastern Europe; North America; Western Europe |
|---|---|
| Affiliated categories: | Cocoa |Confectionery |Dietary supplements More |
